Resource Center
Explore our library of educational resources for RWD industry insights, expert tips, success strategies, and more. Download Brochure
Verana Health and Bitfount Collaborate to Simplify Prescreening for Ophthalmic Clinical Trials
Multimodal approach combining ophthalmic imaging and EHR data improves speed and accuracy of identifying eligible patients for studies San Francisco, CA, October 8, 2026 – Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has announced a new partnership with Bitfount, an on-premise federated AI analysis…
Verana Health Introduces Significant Data and AI Enhancements to Support Ophthalmologic Research and Treatment Optimization
Coinciding with AAO 2026, the American Academy of Ophthalmology’s annual meeting, the company debuts AI Agents for research and datasets for exclusive real-world insights from 90 million+ de-identified patients San Francisco, CA, October 1, 2026 – Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), revealed…
Verana Health Introduces New AI Agents to Expedite and Streamline R&D Tasks
Agent Claire for Life Sciences empowers researchers with conversational access to disease-specific real-world databases San Francisco, CA, September 24, 2026 – Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has announced the release of new artificial intelligence (AI) agents to aid researchers. Agent Claire for…
The Use of Real-World Data and Evidence in Clinical Trials
Tufts Center for the Study of Drug Development (Tufts CSDD) and Verana Health collaborated to examine the use of real-world data (RWD) and real-world evidence (RWE) in clinical trials across pharmaceutical companies and contract research organizations (CROs) in oncology, ophthalmology, neurology, dermatology, and urology…
Transforming Real-World Evidence: How Verana Health is Advancing AI-Powered Clinical Evidence
The life sciences industry is entering a new era where real-world evidence (RWE), artificial intelligence, and large-scale clinical datasets are transforming how pharmaceutical companies design trials, evaluate therapies, and deliver treatments to patients…
Life Sciences Real-World Evidence Solutions, 2025
Tufts Center for the Study of Drug Development (Tufts CSDD) and Verana Health collaborated to examine the use of real-world data (RWD) and real-world evidence (RWE) in clinical trials across pharmaceutical companies and contract research organizations (CROs) in oncology, ophthalmology, neurology, dermatology, and urology…
How AI Agents Are Streamlining Everyday Clinical Operations
Healthcare organizations have spent the past decade digitizing workflows, expanding access to data, and introducing automation to reduce administrative burden. However, for many clinicians and operational teams…
Five Key Strategies to De-Risk with Real-World Data
In the complex, high-risk business of pharmaceutical research and development, sponsors face a challenge of picking target products with high therapeutic potential and acceptable safety profile…
Ovarian Cancer: Closing Gaps and Advancing Care with RWD
Gynecological cancers impact all of us. According to the American Cancer Society, approximately 21,000 women will be diagnosed1 with ovarian cancer in the U.S. in 2026…
Leveraging Real-World Data for Proactive Protocol Design
Clinical trials have grown more complex than ever before. Protocols are becoming more specialized, endpoints more refined, and eligibility criteria narrower and more precise…
Why Real-World Evidence is Becoming the Missing Link Between Innovation and Patient Care in Oncology
Oncology innovation is moving faster than ever. Targeted therapies, immunotherapies, and precision medicine are redefining what is possible for patients…
From Insight to Impact: Making Real-World Evidence Actionable in Urology
Clinical innovation in urology continues to move quickly as new diagnostics, therapies, and data-driven approaches reshape how clinicians understand and manage disease. At the same time…
Enhancing clinical trials with real-world data
In 1747, James Lind conducted one of the earliest comparative trials, testing oranges and lemons to treat scurvy in sailors. In 1948, Austin Bradford Hill designed…
RWD at Scale: How Verana Health and COTA Are Shaping the Future of Clinical Development
C.K. Wang and Sujay Jadhav examine how the recent Verana Health-COTA merger is accelerating the evolution of real-world data (RWD) from a retrospective insight tool…
Real-World Data Brings New Insights to Natural History of Disease Studies
Developing new and better treatments for a disease starts with understanding the disease itself. What are the symptoms, who does it affect, and how…
Proactive Planning is Key to Mitigating Study Rescue
The growing market for clinical trial rescue services—specialized services for rectifying trials that are failing or at risk of significant delay—is a clear indication…
Tokenization: The Unsexy Plumbing of Clinical Research
In an era of digital health, the intersection of data privacy and innovation has become increasingly relevant. More and more, clinical researchers are looking to…
